
Glimpoze PM 1mg/500mg/15mg Tablet SR
Marketer
Shinto Organics (P) Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimpoze PM 1mg/500mg/15mg Tablet SR
Diabetic patients with type 2 mellitus may find blood sugar management aided by the combined-action tablet, Glimpoze PM SR (1mg/500mg/15mg). This medication complements a healthy diet and exercise program, promoting better insulin utilization and subsequently reduced blood glucose. Dosage and frequency should strictly adhere to your physician's instructions. Ingestion with food minimizes potential gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dosage. Overdosage can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other anti-diabetic medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Typical side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-treatment disclosure of any kidney, liver, or heart conditions, along with pregnancy or breastfeeding status, is essential. Kidney function assessment will precede treatment initiation. Limiting alcohol consumption is advised to mitigate potential adverse reactions.
Primary Ingredients of Glimpoze PM 1mg/500mg/15mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Glimpoze PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimpoze PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpoze PM 1mg/500mg/15mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with food.
Common Side effects of Glimpoze PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimpoze PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimpoze PM 1mg/500mg/15mg Extended-Release Tablets should be administered with meals.
How Glimpoze PM 1mg/500mg/15mg Tablet SR works:
Glimpoze PM 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimpoze PM 1mg/500mg/15mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimpoze PM 1mg/500mg/15mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimpoze PM 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimpoze PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. Glimpoze PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when administering Glimpoze PM 1mg/500mg/15mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glimpoze PM 1mg/500mg/15mg Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimpoze PM 1mg/500mg/15mg Tablet SR :
Should you forget to take a Glimpoze PM 1mg/500mg/15mg SR tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimpoze PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
